|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2000037241 |
|
最近更新日期: Date of Last Refreshed on: |
2020-08-27 11:23:38 |
|
注册时间: Date of Registration: |
2020-08-27 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
请与我们联系上传伦理批件 “九味永安汤”治疗特应性皮炎(血虚风燥证)的临床研究 |
|
Public title: |
Clinical study of jiuwei Yongan Decoction in treating atopic dermatitis (blood deficiency, wind dryness syndrome) |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
“九味永安汤”治疗特应性皮炎(血虚风燥证)的临床研究 |
|
Scientific title: |
Clinical study of jiuwei Yongan Decoction in treating atopic dermatitis (blood deficiency, wind dryness syndrome) |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
陈婷如 |
研究负责人: |
杨延龙 |
|
Applicant: |
Tingru Chen |
Study leader: |
Yanlong Yang |
|
申请注册联系人电话: Applicant telephone: |
13918825091 |
研究负责人电话: Study leader's telephone: |
13524420985 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
504731593@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
yanlongyangzy@163.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
上海市杨浦区翔殷路800号中医系 |
研究负责人通讯地址: |
上海市杨浦区翔殷路800号中医系 |
|
Applicant address: |
Department of TCM, No 800, Xiangyin Road, Yangpu district, Shanghai |
Study leader's address: |
Department of TCM, No 800, Xiangyin Road, Yangpu district, Shanghai |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
中国人民解放军海军军医大学第一附属医院 |
||
|
Applicant's institution: |
Shanghai Changhai Hospital |
||
|
研究负责人所在单位: |
|
||
|
Affiliation of the Leader: |
|
||
|
是否获伦理委员会批准: |
是/Yes |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
CHEC-Y2020-027 |
伦理委员会批件附件: Approved file of Ethical Committee: |
|
|
批准本研究的伦理委员会名称: |
上海长海医院伦理委员会 |
||
|
Name of the ethic committee: |
Ethics Committee of Shanghai Changhai Hospital |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2020-08-24 00:00:00 |
||
|
伦理委员会联系人: |
计一平 |
||
|
Contact Name of the ethic committee: |
YipingJi |
||
|
伦理委员会联系地址: |
上海市杨浦区长海路168号16号楼2楼 |
||
|
Contact Address of the ethic committee: |
Floor 2, Building 16, No 168, Changhai Road, Yangpu District, Shanghai |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
||
|
研究实施负责(组长)单位: |
中国人民解放军海军军医大学第一附属医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Shanghai Changhai Hospital |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
上海市杨浦区长海路168号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No 168, Changhai Road, Yangpu District, Shanghai |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
上海申康医院发展中心 |
||||||||||||||||||||||
|
Source(s) of funding: |
Hospital Development Center |
||||||||||||||||||||||
|
Target disease: |
Atopic dermatitis |
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
I期临床试验 | ||||||||||||||||||||||
|
Study phase: |
1 |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
通过随机对照试验评估“九味永安汤”能否改善血虚风燥型特应性皮炎患者的皮损情况及瘙痒程度并评估其安全性。 |
||||||||||||||||||||||
|
Objectives of Study: |
A randomized controlled trial was conducted to evaluate whether jiuwei Yongan Decoction can improve the skin lesions and itching degree of patients with atopic dermatitis with blood deficiency and wind dryness, and to evaluate its safety. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
(1)符合西医诊断标准; |
||||||||||||||||||||||
|
Inclusion criteria |
(1) Accord with the diagnostic criteria of Western medicine; |
||||||||||||||||||||||
|
排除标准: |
(1)有严重的原发疾病,如心脑血管,脑血管,肝,肾和造血系统,精神病患者; |
||||||||||||||||||||||
|
Exclusion criteria: |
(1) Patients with serious primary diseases, such as cardio-cerebrovascular, cerebrovascular, liver, kidney and hematopoietic system, and psychosis; |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2020-10-01 00:00:00至 To 2022-09-30 00:00:00 |
征募观察对象时间: Recruiting time: |
从From 2020-10-01 00:00:00 至 To 2022-06-30 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男性 |
Gender: |
Male |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
随机分配方法由长海医院中医外科研究人员,采取简单随机对照化的方法,运用SPSS软件产生一组随机序列,制成卡片后分别装入标有序号的不透明信封中。患者按照入组顺序抽取信封,并且按卡片编号的规定进行分组和观察治疗。分为治疗组、对照组,两组各本研究严格遵循生物学伦理原则,已告知患者本试验的目的、意义及过程,对患者资料严格保密,所采集的数据仅限本试验使用。凡符合纳入标准的患者,在获得签名的书面知情同意书后进行随机分配。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
Random assignment Method A simple randomized controlled method was adopted by researchers of Traditional Chinese medicine surgery in Changhai Hospital. SPSS software was used to generate a group of random sequences, which were then made into CARDS and placed into opaque envelopes with serial Numbers.The patients we |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
|
|
Blinding: |
|
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
采用网络平台,中国临床试验注册中心 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
Adopt network platform, China Clinical Trial Registry |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
病例记录表 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Case Record Form, CRF |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |